Tag Archives: Early Diagnosis of Alzheimer’s Disease

Digital Technology for Early Detection of Neurodegenerative Disease (BBC News / EDoN)

Posted on February 15, 2020 by Dementia and Elderly Care News

Summary The Early Detection of Neurodegenerative Diseases (EDoN) initiative, with backing from Alzheimer’s Research UK, is working to develop wearable devices which will collect data to help detect the early stages of Alzheimer’s Disease and other neurodegenerative diseases. Full Text … Continue reading →

Posted in Alzheimer’s Research UK, BBC News, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Parkinson's Disease, Quick Insights, UK, Universal Interest | Tagged Accelerating Detection of Disease Programme, Alan Turing Institute, Alzheimer's Disease: Diagnosis, Alzheimer’s Disease, Alzheimer’s Research UK (ARUK), Artificial Intelligence (AI), ARUK: Alzheimer’s Research UK, Asymptomatic Alzheimer’s Disease, Automatic Speech Analysis, BBC Health News, BBC Technology News, Behavioural Biomarkers, Benefits of Early Detection, Big Data, Bill and Melinda Gates Foundation, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, CrawfordWorks, David Cameron, David Cameron: Former Prime Minister, Digital Biomarkers, Digital Diagnostic Tools, Digital Fingerprints, Digital Technology, Digital Technology and Innovation, Early Detection of Alzheimer’s Disease, Early Detection of Disease, Early Detection of Neurodegenerative Diseases, Early Detection of Neurodegenerative Diseases (EDoN), Early Detection of Preclinical Disease, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Diagnosis of Dementia, Early Recognition of Alzheimer’s Disease Using Digital Technology, Early Recognition of Neurodegenerative Diseases Using Digital Technology, EDoN Clinical Support Group, EDoN Cohorts and Biomarkers Working Group, EDoN Digital Platform Working Group, EDoN Digital Support Group, EDoN Digital Toolkit, EDoN Digital Tools Working Group, EDoN Fingerprint Analytics Working Group, EDoN White Paper, Ethical Considerations, Ethical Sharing of Data Between Organisations, Fingerprint Analytics, Gait: an Integrative Measure of Health, Heart Rate, Iceland Foods Charitable Foundation, Information Technology, International and Independent External Advisory Board, Investment in Information Technology, Machine Learning Models, Medopad, Mild Cognitive Impairment (MCI), Mindstrong Health, MRC Harwell Institute, National Hospital for Neurology and Neurosurgery: University College London, National Physical Laboratory, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Newcastle University, Non-Invasive Biomarkers, Optimising Benefits of Digital Technology, Preclinical Alzheimer's Disease, Preclinical Biomarkers and Dementia, Preclinical Biomarkers in Alzheimer's Disease, Preclinical Dementia and Associated Lifestyle Changes, Preclinical Indicators and Dementia, Preclinical Indicators in Alzheimer's Disease, Preclinical Phase of Dementia, Prodromal Alzheimer's Disease, Prodromal Dementia, Rates of Conversion From Mild Cognitive Impairment to Dementia, Research Informatics, Sleep Patterns, Smart Phone apps, Smart Sensors, Smart Watches, Target Discovery and Preclinical Validation, Tencent, The Rt Hon David Cameron: Chair of EDoN Board, The Rt Hon David Cameron: President of Alzheimer’s Research UK, Timely / Preclinical Neurodegenerative Diseases Diagnosis, Timely Screening / Preclinical Neurodegenerative Disease, University College London, University of Cambridge, University of Exeter, University of Oxford Big Data Institute, Walking Speed: a Behavioural Biomarker for Neurocognitive and Physical Decline, Wearable Devices, Wearable Monitoring Equipment, Wearable Sensors, Wearable Technology, Wearables (Technology) | Leave a comment

Blood Test Able to Predict Alzheimer’s Disease Decades Before Symptoms? (BBC News / Neurology)

Posted on August 3, 2019 by Dementia and Elderly Care News

Summary Research published in the Neurology journal claims a significant breakthrough in the development of a blood test (for plasma Aβ42/Aβ40) which may be able to predict Alzheimer’s Disease onset with 94% accuracy. Due caution: “But it’s important to note … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Quick Insights, Universal Interest | Tagged Alzheimer's Disease: Diagnosis, Alzheimer’s Early Screening, Amyloid, Amyloid and Tau PET, Amyloid Beta, Amyloid Beta (Aβ42 and Aβ40), Amyloid Beta Protein, Amyloid-β (Aβ), Amyloid-β Protein, BBC Health News, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Blood Proteins as Biomarkers of Disease Research, Blood Test for Brain Amyloidosis: Validated Using Amyloid PET and CSF p-tau181/Aβ42 as Reference Standards, Blood Tests, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brain Imaging, Brain Research, Case Finding, Conversion to Dementia From Prodromal Disease, Dementia Diagnosis, Dementia Innovation, Dementia Research, Dementia Screening, Department of Neurology: Washington University, Diagnosis, Diagnosis of Alzheimer's Disease, Diagnostic Imaging, Division of Biostatistics: Washington University, Drug Development for Alzheimer's Disease, Early Detection of Preclinical Disease, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Hope Center for Neurological Disorders: Washington University, Knight Alzheimer's Disease Research Center: Washington University, Mallinckrodt Institute of Radiology: Washington University, Neurology (Journal), Non-Invasive Biomarkers, Plasma Biomarkers, Plasma β-Amyloid 42/40, Plasma Protein Markers of MRI Measures in Asymptomatic Individuals, Preclinical Alzheimer's Disease, Preclinical Biomarkers in Alzheimer's Disease, Predictive Ability (of Tests), Prodromal Alzheimer's Disease, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Rapid Screening, Recruitment Onto Dementia Clinical Trials, SAP (Protein), SAP: Serum Amyloid Protein, Screening, Screening for Dementia, Washington University School of Medicine | Leave a comment

Dementia Biomarkers Re-Explored? (General Psychiatry / JGCR)

Posted on June 17, 2019 by Dementia and Elderly Care News

Summary A recent systematic review examines biomarkers, as strictly defined, for neurodegenerative diseases. “Vast improvements in neuroimaging techniques have led to newly discovered biomarkers and diagnostics”. p.5 Behavioural biomarkers are mentioned hardly at all. Full Text Link Reference Maclin, JMA. … Continue reading →

Posted in Alzheimer’s Research UK, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Mental Health, Personalisation, Quick Insights, Systematic Reviews, UK, Universal Interest | Tagged 18F-florbetaben, 18F-flutemetamol, 18Fflorbetapir, Alzheimer's Disease: Diagnosis, Alzheimer’s Disease, Alzheimer’s Disease and Dementia, Alzheimer’s Disease Biomarkers, Alzheimer’s Research UK (ARUK), Amyloid and Tau PET, APOE e4 (Apolipoprotein E e4), Apolipoprotein E (APOE) e4 Allele, Behavioural Biomarkers, Beta-Amyloid PET Imaging, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Canonical Syndromes of Primary Progressive Aphasia: Non-Fluent / Agrammatic Variant (nfvPPA), Canonical Syndromes of Primary Progressive Aphasia: Semantic Variant (svPPA), Carbon-11 Pittsburgh Compound-B (C-PIB) Radioisotope Tracer, Cerebral Metabolic Rate for Glucose (CMRgl), Cerebrospinal Fluid (CSF) Biomarkers, Cerebrospinal Fluid and Serum MHPG, CMRgl Decline, Corticobasal Degeneration (CBD), CSF 3-methoxy-4-hydrox-yphenylglycol (MHPG), Dementia With Lewy Bodies (DLB), Differential Diagnosis, DLB: Dementia with Lewy Bodies, Docosahexaenoic Acid (DHA), Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Eicosapentaenoic Acid (EPA), Frontotemporal Dementia (FTD), α-Synuclein, Journal of Geriatric Care and Research (JGCR), Lewy Body Dementia (LBD), Magnetic Resonance Imaging (MRI), Medial Temporal Lobe Atrophy (MTA), Medial Temporal Lobes (MTL), Metabolic Syndrome (MetS), MRI Brain Imaging, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neuroimaging, Neuroimaging in Dementia Diagnosis, Non-Invasive Biomarkers, Pick’s Disease (Frontotemporal Dementia), Positron Emission Tomography (PET), Preclinical Alzheimer's Disease, Primary Progressive Aphasia (PPA), Progressive Supranuclear Palsy (PSP), Rapid Screening, Screening for Dementia, Sea Hero Quest (SHQ) Game, Sea Hero Quest VR, Tau PET, Timely Diagnosis, VaD: Vascular Dementia, Variants of Primary Progressive Aphasia (PPA), Vascular Dementia, [18F]THK5351 | Leave a comment

Eye Tests for Early Detection of Alzheimer’s Disease? (NHS Digital / Ophthalmology Retina)

Posted on March 20, 2019 by Dementia and Elderly Care News

Summary Further discussion about the possibilities of using inexpensive eye tests to detect Alzheimer’s Disease, perhaps years before symptoms appear. This particular technique involves the examination of blood vessels and blood flow in the retina, as detected by Octa (Optical … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest | Tagged Alzheimer's Disease: Diagnosis, Alzheimer’s Disease, Alzheimer’s Disease and Dementia, Alzheimer’s Disease Biomarkers, Assessment and Diagnosis, Bazian, Behind the Headlines, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Central Subfield Thickness (CST), Cognitive Impairment, Critical Appraisals, Dementia Case Finding, Dementia Diagnosis, Dementia Screening, Diagnosis, Diagnosis of Alzheimer's Disease, Diagnostics, Duke University in North Carolina, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Treatment Diabetic Retinopathy Study, Eye Examinations, Foveal Avascular Zone (FAZ) Area, Karen L. Wrenn Alzheimer's Disease Award, Macular Ganglion Cell-Inner Plexiform Layer (GC-IPL), MCI: Mild Cognitive Impairment, Mild Cognitive Impairment, National Institutes of Health, National Institutes of Health (NIH), National Institutes of Health (US), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, NHS Digital (Formerly NHS Choices), Non-Invasive Biomarkers, Octa: Optical Coherence Tomography Angiography, Ophthalmology Retina, Optical Coherence Tomography, Optical Coherence Tomography Angiography (OCTA), Preclinical Alzheimer's Disease, Rapid Screening, Research to Prevent Blindness Inc. (New York), Retina as Early Biomarker of Neurodegeneration, Retinal Biomarkers, Retinal Examination in Neurodegenerative Diseases, Retinal Microvascular and Neurodegenerative Changes in Alzheimer’s Disease, Retinal Microvascular and Neurodegenerative Changes in Mild Cognitive Impairment, Retinal Vessel Density (VD), Screening, Screening for Dementia, Timely Diagnosis, US National Institutes of Health (NIH), USA | Leave a comment

More on Possible Blood Tests for Pre-Symptomatic Alzheimer’s Disease (NHS Digital / Nature Medicine)

Posted on January 28, 2019 by Dementia and Elderly Care News

Summary People with a rare hereditary form of Alzheimer’s Disease (Dominantly Inherited Alzheimer’s Disease) have raised levels of a protein called neurofilament light chain (NfC) in their blood, arising from damage to previously healthy nerve cells. These elevated levels of … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest | Tagged APP or PSEN Mutations, Australia, Basel, Bazian, Behind the Headlines, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Blood Proteins as Biomarkers of Disease Research, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Columbia University Medical Center, Dementia Research Centre, Dementia Research Centre: University College London, Department of Biomedical Sciences: Macquarie University, Department of Cellular Neurology: Hertie Institute for Clinical Brain Research, Department of Neurodegeneration: Queen Square Institute of Neurology, Department of Neurology: Columbia University Medical Center, Department of Neurology: Keck School of Medicine at USC, Department of Neurology: Ludwig-Maximilians-Universität München, Department of Neurology: Massachusetts General Hospital, Department of Neurology: Mayo Clinic Jacksonville, Department of Neurology: Washington University School of Medicine, Department of Neuroscience: Icahn School of Medicine at Mount Sinai, Department of Psychiatry and Psychotherapy: University of Tübingen, Department of Radiology: Washington University School of Medicine, Departments of Medicine Biomedicine and Clinical Research: University Hospital Basel, Division of Biostatistics: Washington University School of Medicine, Dominantly Inherited Alzheimer Network, Dominantly Inherited Alzheimer Network (DIAN), Dominantly Inherited Alzheimer's Disease, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Edith Cowan University: Western Australia, Florey Institute of Neuroscience and Mental Health: University of Melbourne, German Center for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Germany, Harvard Medical School, Hereditary Alzheimer's Disease, Hertie Institute for Clinical Brain Research, Icahn School of Medicine at Mount Sinai (New York), Indiana Alzheimer Disease Center and Department of Pathology and Laboratory Medicine: Indiana University School of Medicine, Indiana University School of Medicine, Ludwig-Maximilians-Universität München, Macquarie University, Macquarie University (New South Wales), Massachusetts General Hospital, National Institute on Aging, National Institute on Aging (NIA), National Institute on Aging (US), Nature Medicine, Neurodegeneration Division: The Florey Institute of Neuroscience and Mental Health, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurofilament Light Chain (NfC), Neurofilament Light Chain (NFL), Neurofilament Light Protein (NF-L), Neurofilament Light Protein in Blood: Potential Biomarker of Neurodegeneration, Neurologic Clinic and Policlinic: University Hospital Basel, Neuroscience Research Australia, Non-Invasive Biomarkers, Plasma Biomarkers, Preclinical Alzheimer's Disease, Preclinical Biomarkers and Dementia, Preclinical Biomarkers in Alzheimer's Disease, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, School of Medical Health and Sciences: Edith Cowan University, School of Medical Sciences: University of New South Wales, Serum Neurofilament Light Chain Protein, Switzerland, Taub Institute for Research on Alzheimer's Disease and the Aging Brain: Columbia University Medical Center, United States, University College London, University Hospital Basel, University of Basel, University of Melbourne, University of New South Wales, University of Tübingen, US National Institute on Aging, USA, Warren Alpert Medical School of Brown University, Washington University School of Medicine | Leave a comment

Transformation of Health and Care in Wales: a Revolution from Within (BBC News / Welsh Government)

Posted on January 16, 2018 by Dementia and Elderly Care News

Summary The Parliamentary Review of Health and Social Care in Wales provides an inspiring vision of future directions in service provision, with proposals which are likely to be studied more widely. Dr Ruth Hussey the former Chief Medical Officer for … Continue reading →

Posted in BBC News, Commissioning, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, National, NHS, Non-Pharmacological Treatments, Parkinson's Disease, Person-Centred Care, Personalisation, Quick Insights, SCIE, Standards, Statistics, Stroke, Telecare, Telehealth, UK, Universal Interest, Wales | Tagged A Revolution from Within: Transforming Health and Care in Wales, Achieving Better Value, Adoption of Innovations, Aneurin Bevan University Health Board (ABUHB), Bangor University, Best Value for Taxpayers, Board of Community Health Councils (CHCs), Bureaucracy and Culture, Canterbury District Health Board: DHB (New Zealand), Capacity and Capability, Capacity to Care, Care Closer to Home, Carer Support, Carer Support in Wales, Carer Support Services, Carers Trust Wales, Carers Wales, Change Management, Change Management and Empowerment, Commissioning Carer Support Services, Commissioning for Value, Communities First, Community Health Councils (CHCs), Continuing Learning and Development, Continuous Quality Improvement, Coordinated Health and Social Care, Dementia Awareness Training, Dementia Screening, Dementia Training, Dementia-Friendly Hospitals, Digital Technology, Digital Technology and Innovation, Discharge From Hospital to Primary Care, Dr Chineze Ivenso: Chair of Old Age Faculty at Royal College of Psychiatrists in Wales, Dr David Bailey: Chairman of BMA Wales, Dr Jennifer Dixon CBE (Health Foundation), Dr Ruth Hussey: Former Chief Medical Officer for Wales, Early Diagnosis of Alzheimer's Disease, Early Diagnosis of Dementia, Eric Gregory: Chair of the Assembly Commission Audit and Risk Assurance Committee, Experience of Care, First 1000 Days Collaborative, Future Generation Goals, Global and National Perspective on Dementia (National Assembly for Wales), Good Governance, Great Place to Work, Health and Social Care Reform, Health Education and Improvement Wales (HEIW), Health Technology Wales (HTW, Helen Howson: Director of Bevan Commission (Think-Tank), Impact of Delayed Health Treatment in Wales (Our Lives on Hold: Report), Improving Population Health, Innovation, Innovation Technology and Infrastructure, Integration, Integration of Health and Social Care, International Consortium for Health Outcomes Measurements (ICHOM), Jönköping County Council, Jönköping County Council: Sweden, Joined-Up Care, Joined-Up Strategy to Improve Whole System Flow, Learning and Developing Continuously, Learning Culture, Life Sciences Hub Wales, Listening and Learning System, Listening to Patients, Listening to Patients Families and Staff, Long-Term Care (LTC), Long-Term Care and Support, Making Change Happen, Making Choices Together, Making Choices Together (Previously Choosing Wisely Wales), Moving Healthcare Closer to Home, My Health Text, National Assembly for Wales, National Transformation Programme (Wales), New Models of Care, New Models of Care Vanguards, New Models of Seamless Care, NHS 70 Celebrations, NHS Productivity, NHS Sustainability, NHS Wales Delivery Framework, NHS Wales Efficiency and Healthcare Value Improvement Group (NWEHVIG), NHS Wales Shared Services Partnership (NWSSP), NHS’s 70th Birthday, Nigel Edwards: Nuffield Trust, Nuka System, Nuka System of Care, Once for Wales Principles, Parliamentary Review of Health and Social Care in Wales, Parliamentary Review of Health and Social Care in Wales: Interim Report (2017), Partnership and Collaboration, Partnership Working, Patient Experience, People in Control, PET Scans, Population Health, Population Health and Prevention, Positron Emission Tomography (PET), Preventative Support for Adult Carers, Preventative Support for Adult Carers in Wales (SCIE Rapid Review), Preventative Support for Carers, Principles of Good Governance, Productivity, Professor Anne Marie Rafferty: Dean of Florence Nightingale School of Nursing and Midwifery at King's College London, Professor Chris Marshall: Wales Research and Diagnostic PET Imaging Centre, Professor Dame Carol Black DBE, Professor Don Berwick, Professor Keith Moultrie: Institute of Public Care at Oxford Brookes University, Professor Sir Mansel Aylward, Prosperity for All (Welsh Government), Prudent Health Care, Prudent Healthcare (Bevan Commission), Public Health Wales, Public Service Boards (PSBs), Quadruple Aim for All, Quality and Sustainability, Quality Improvement, Quality of Care, Reduction in Bureaucracy, Royal College of Psychiatrists in Wales, Screening for Dementia, Seamless Care Between Settings, Seamless System for Wales, Shared Decision-Making, Shared Lives Wales, Situational Analysis, Social Care Institute for Excellence (SCIE), Social Care Wales (SCW), Social Services and Wellbeing Act Principles, Staff Engagement, Staff Shortages, Systems for Change, Team Manager Development Programme for Wales, Technology and Infrastructure Development, Transforming Health and Care in Wales, Tredegar Workmen’s Medical Aid Society, University Hospital of Wales (UHW), Value for Money, Vanessa Young: Director of NHS Confederation, Vaughan Gething: Welsh Health Secretary, Wales Research and Diagnostic PET Imaging Centre, Wellbeing of Future Generations (Wales) Act, Wellbeing of the Health and Care Workforce, Welsh Community Care Information System (WCCIS), Welsh Government, Welsh Institute for Health and Social Care: University of South Wales, Welsh Language, WHO Global Action Plan on the Public Health Response to Dementia 2017-2025, Whole System Integration, Whole Systems Redesign, Whole-System Approaches | Leave a comment

Earlier Diagnosis of Alzheimer’s Disease Using Saliva Test? (NHS Choices / JAD)

Posted on May 25, 2017 by Dementia and Elderly Care News

Summary Pilot research indicates that a chemical in the saliva can be used to differentiate, with relatively high accuracy, between persons who are currently healthy, those with mild cognitive impairment (MCI), and others with Alzheimer’s Disease. Potentially, salivary biomarkers could … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest | Tagged 1H NMR-Based Metabolomics, Alzheimer’s Disease Biomarkers, Alzheimer’s Early Screening, Beaumont Health, Beaumont Research Institute: Beaumont Health, Behind the Headlines, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Canada, Dementia Saliva Testing (Pilot Study), Dementia Screening, Departments of Biological and Computing Sciences: University of Alberta, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Diagnosis of Alzheimer’s Disease Using Saliva, Fred A. and Barbara M. Erb Family Foundation, JAD, Journal of Alzheimer's Disease, MCI: Mild Cognitive Impairment, Metabolomics, Mild Cognitive Impairment (MCI), NHS Digital (Previously NHS Choices), Non-Invasive Biomarkers, Nuclear Magnetic Resonance Spectroscopy (NMR), Oakland University, Potential for Metabolomics and Saliva in Early Diagnosis of Alzheimer’s Disease, Preclinical Biomarkers and Dementia, Preclinical Biomarkers in Alzheimer's Disease, Saliva, Saliva Tests, Salivary Biomarkers, Screening, Screening for Dementia, Screening Tests, Surrogate Biomarkers of Neurodegeneration, United States, University of Alberta, USA, William Beaumont School of Medicine: Oakland University | Leave a comment

Earlier Diagnosis of Glaucoma – and Possibly Many Neurodegenerative Diseases – By Retinal Examination? (BBC News / NHS Choices / Brain)

Posted on May 1, 2017 by Dementia and Elderly Care News

Summary A fluorescent dye injected into the bloodstream may, in future, provide a convenient method of detecting glaucoma earlier – perhaps a decade before more overt symptoms and damage have had the opportunity to develop – by identifying changes in … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, NHS Digital (Previously NHS Choices), Parkinson's Disease, Quick Insights, UK, Universal Interest | Tagged Annexin 5 Labelled With Fluorescent Dye DY-776 (ANX776), ANX776 Pharmacokinetics and Pharmacodynamics, ANX776-Positive Fluorescent Cells, Apoptosis, Apoptotic Cells in Neurodegenerative Diseases, Apoptotic Neural Cell Death, Assessment and Diagnosis, BBC Health News, Behind the Headlines, Bethan Hughes: Wellcome Trust, Brain (Journal), Centre for Medical Image Computing: University College London, DARC: Detection of Apoptosing Retinal Cells, Dementia Diagnosis, Department of Visual Neuroscience: UCL Institute of Ophthalmology, Detection of Apoptosing Retinal Cells (DARC), Diagnostic Imaging, Diagnostic Markers, Diagnostic Testing, Drusen (Spots on Retina), Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Diagnosis of Parkinson’s Disease, Eye Cells, Eye Examinations, Glaucoma, Glaucoma and Retinal Neurodegeneration Group: UCL Institute of Ophthalmology, Glaucomatous Neurodegeneration, Imperial College London, Imperial College Ophthalmic Research Group (ICORG), Intravenous ANX776, Levels of Apoptosis (DARC Count), London, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neuronal Cell Apoptosis in Patients With Glaucoma, Neuronal Loss, Ocular Neurodegenerative Conditions, Potential of DARC as Surrogate Biomarker. Retinal Ganglion Cell Apoptosis, Retinal Assessments Using DARC (Detection of Apoptosing Retinal Cells), Retinal Cell Apoptosis, Retinal Ganglion Cell Layer, Retinal Nerve Fibre Layer (RNFL), Timely Diagnosis, Translational Imaging Group: University College London, UCL Institute of Ophthalmology, University College London, Western Eye Hospital, Western Eye Hospital: Imperial College Healthcare NHS Trust, Western Eye Hospital: Imperial College Healthcare NHS Trust (ICHNT) | Leave a comment

Under-Diagnosis of Dementia in the Community: an International Review (BMJ Open / JGCR)

Posted on February 8, 2017 by Dementia and Elderly Care News

Summary A literature review and meta-analysis of 23 international studies on the under-detection (i.e. the failure to achieve a diagnosis) of dementia identified a pooled rate of undetected dementia assessed to be 61.7%. The rate of under-detection was higher in … Continue reading →

Posted in Acute Hospitals, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), International, Models of Dementia Care, Quick Insights, Royal Wolverhampton NHS Trust, Royal Wolverhampton NHS Trust Authorial Affiliation, Statistics, UK, Universal Interest, Wolverhampton | Tagged Academic Institute of Medicine: University of Wolverhampton, Affluence and Health Inequalities, Age and Gender Differences in Diagnosis Rates, Agewell Foundation (India), Anhui Medical University, Assessment and Diagnosis, Australia, Australian National University, Barriers to Early Diagnosis, BMJ Open, BMJ Publishing Group Ltd, Case Finding, Case Finding for Patients with Dementia, Centre for Research on Ageing Health and Wellbeing: Australian National University, China, Cognitive Assessment Tools, Cognitive Impairment, Dementia Case Finding, Dementia Case Finding Scheme, Dementia Challenge, Dementia Collaborative Research Centre-Early Diagnosis and Prevention: Australian National University, Dementia Diagnosis, Dementia Screening, Dementia Screening Debate, Department of Practice and Policy: University College London, Department of Psychiatry: University of Liverpool, Department of Public Health: Wolverhampton City Council, Diagnosis and Referral, Diagnosis and Support, Diagnosis at Primary Care Level, Diagnosis Gap, Diagnosis of Dementia, Diagnosis Rates, Dignity Foundation (India), Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Screening, Effectiveness of Early Detection and Treatment, Ethical Considerations, Ethical Dilemmas, Ethical Issues of Dementia Care, Ethics and Decision-Making, Europe, Faculty of Education Health and Wellbeing: University of Wolverhampton, General Practice, Geriatric Care and Research Organisation (GeriCaRe), GPs, Health Inequalities, HelpAge India, India, Journal of Geriatric Care and Research (JGCR), Liverpool, Mental Health Inequalities, Mini Mental State Examination (MMSE), National Programme for the Health Care of the Elderly (NPHCE), New Cross Hospital: Royal Wolverhampton NHS Trust, North America, Post Graduate Academic Institute of Medicine: University of Wolverhampton, Reducing Health Inequalities, Research School of Population Health: Australian National University, Royal Wolverhampton NHS Trust, School of Health Administration: Anhui Medical University, Screening, Screening for Cognitive Impairment, Screening for Cognitive Impairment in Older Adults, Screening for Dementia, Screening Programmes, Screening Tests, Socio-Economic Differences in Diagnosis Rates, Timely Diagnosis, UK National Screening Committee (UK NSC), Under-Detection of Dementia, University College London, University of Liverpool, University of Wolverhampton, Wolverhampton City Council | 1 Comment

European Medicines Agency Consultation on Pharmacological Treatments for Dementia (EMA)

Posted on February 3, 2016 by Dementia and Elderly Care News

Summary The European Medicines Agency (EMA) has released an updated draft guideline on medicines for the treatment of Alzheimer’s Disease and other types of dementia, for consultative feedback. Full Text Link Reference Consultation on revised guideline on medicines to treat … Continue reading →

Tag Archives: Early Diagnosis of Alzheimer’s Disease

Blood Test Able to Predict Alzheimer’s Disease Decades Before Symptoms? (BBC News / Neurology)

Dementia Biomarkers Re-Explored? (General Psychiatry / JGCR)

Eye Tests for Early Detection of Alzheimer’s Disease? (NHS Digital / Ophthalmology Retina)

More on Possible Blood Tests for Pre-Symptomatic Alzheimer’s Disease (NHS Digital / Nature Medicine)

Earlier Diagnosis of Alzheimer’s Disease Using Saliva Test? (NHS Choices / JAD)

Earlier Diagnosis of Glaucoma – and Possibly Many Neurodegenerative Diseases – By Retinal Examination? (BBC News / NHS Choices / Brain)

European Medicines Agency Consultation on Pharmacological Treatments for Dementia (EMA)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites